About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Mar 23, 2021... How did scientists develop an effective vaccine for Covid-19 in less than a year? In this webinar, the American Committee welcomed Dr. Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development, and Medical at Pfizer. In conversation with former American Committee President and renowned AIDS researcher Dr. Jay Levy, Dr. Dolsten shed light on the breakthroughs that enabled his team, in collaboration with researchers around the world, to produce a viable vaccine at such an extraordinary speed. He also shared his own scientific journey, including the transformative semester he spent at the Weizmann Institute as a PhD student. During a dynamic Q&A led by CEO Dave Doneson, Dr. Dolsten discussed the role of basic science in advancing lifesaving technologies and treatments.
https://www.weizmann-usa.org/news-media/in-the-news/could-one-shot-kill-the-flu/
Nov 22, 2021... Renowned Weizmann scientist, Prof. Ruth Arnon, recently spoke to the New Yorker Magazine about a universal flu vaccine. Arnon joined the Institute in 1960 and has devoted her career to pioneering groundbreaking medications and vaccines. As Chair of BiondVax’s Scientific Advisory Board—an Israeli biopharmaceutical company developing a universal flu vaccine—and as the Paul Ehrlich Chair in Immunochemistry at the Weizmann, she is globally recognized as a leading expert in her field. Few scientists working today have the decades of rich experience Arnon still brings to the table.
©2022 American Committee for the Weizmann Institute of Science
